CClinicalTrials.gg
Status unknownNCT03266406Updated Aug 30, 2017

Effect of Hyaluronidase on Intraocular Pressure

An interventional study of Hyaluronidase in Intraocular Pressure Low, sponsored by Assiut University. Status unknown. Open to participants aged 50 Years to 80 Years. Per ClinicalTrials.gov, last updated 2017-08-30.

Sponsored by Assiut University · Not applicable, Interventional, and Diagnostic

The sponsor has not verified this record recently (last verified Aug 2017), so the status shown — last known as Not yet recruiting — may be out of date.
Phase
Not applicable
Study type
Interventional
Enrollment
50
Allocation
Not applicable
Ages
50 Years to 80 Years
Sex
All
01

Study summary

The aim of this study is to evaluate effect of retrobulbar local anaesthesia after addition of hyaluronidase on IOP during cataract surgery

02

Conditions studied

  • Intraocular Pressure Low
03

Who can participate

Ages eligible
50 Years to 80 Years
Sexes eligible
All
Accepts healthy volunteers
No

Inclusion criteria

  • 1-Patients above the age of 50 years. 2-Patients with age related cataract. 3-Normal IOP.

Exclusion criteria

Exclusion Criteria:

  • 1History of trauma. 2-Patients with glaucoma. 3-Previous ocular surgery. 4-Patients with other ocular pathology. 5-Uncontrolled diabetes or hypertension. 6-hypersensitivity to lignocaine. 7-Uncooperative or epileptic patients.
04

Study design

Phase
Not applicable
Primary purpose
Diagnostic
Allocation
Not applicable
Intervention model
Single group
Masking
None (open label)
Enrollment
50 participants (estimated)

Study arms

  • Experimental
    Effect of hyaluronidase on IOP

    Drug: Hyaluronidase

Interventions

  • DrugHyaluronidase

    4ml of retrobulbar LA with addition of 15IU/ml hyaluronidase to 2% lidocaine

05

What researchers measure

Primary outcomes

  1. reduction in IOP

    reduction of complications of high IOP during surgery

    Time frame: within 10minutes

06

Study locations

No study locations are listed for this record.

07

Registry details

Key details

Study ID
NCT03266406
Lead sponsor
Assiut University
Responsible party
Eman Yassin Ahmed (Principal Investigator, Assiut University) — Principal investigator
First posted
Aug 30, 2017
Start date
Sep 2017 (estimated)
Primary completion
Sep 2018 (estimated)
Completion
Oct 2018 (estimated)
Last update
Aug 30, 2017

Study contacts

Eman Yassin
Contact
emanyassin08@gmail.com
00201004686028

Oversight

FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is status unknown, as verified in Aug 2017. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion